Metformin (off-label longevity use)
Research Reliability -
A decades-old diabetes drug some longevity researchers use off-label for AMPK activation — prescription required.
Appetite
Mood
Sleep
Metformin (off-label longevity use)
Description
Metformin activates AMPK, a master cellular energy sensor that mimics some of the metabolic effects of caloric restriction, and large observational studies in diabetics have noted lower rates of cancer and all-cause mortality compared to non-diabetics on other medications. This drove the ongoing TAME (Targeting Aging with Metformin) trial interest and its adoption by some longevity-focused physicians for non-diabetic patients, despite the human longevity benefit remaining unproven in healthy populations. Importantly, metformin can blunt some of the muscle-building and cardiovascular adaptations from exercise when taken around training, which is why many longevity physicians have patients time doses away from workouts. This is a prescription medication — it requires physician oversight, regular kidney function monitoring, and is not something to self-source.
Effects
First days
glucose drops; gut side effects common early
Weeks
GI effects usually settle
Long term
longevity benefit is unproven and under study
How it Feels
This is a prescription drug, not a supplement, and requires a doctor. The felt experience early on is usually digestive: nausea, loose stools, or cramping that often settles over weeks. Any longevity rationale is speculative and separate from its proven glucose effect.
Usage
Entry Dose
Prescription only
Standard Dose
Prescription only — typically 500mg, physician-titrated
Max Dose
Prescription only — set by prescribing physician
Onset
Days (glucose); years (longevity endpoints, unproven)
Combinations
Pairs well with
Synergistic
B12 — metformin depletes B12 over long-term use, so co-supplementation is standard practice
Timing away from resistance training — preserves the hypertrophy and mitochondrial biogenesis signals metformin can blunt
Avoid combining
Contraindicated
Self-administration without a prescription and physician monitoring — not appropriate or legal
Impaired kidney function — risk of lactic acidosis, a rare but serious complication
Heavy alcohol use — raises lactic acidosis risk
Contrast dye procedures — typically held before and after imaging studies
Biomarkers to Track
Subjective
(Daily)
Energy and digestive tolerance
Appetite and weight trend
Exercise recovery
Objective
(Quarterly)
Fasting glucose and HbA1c
eGFR (kidney function)
Vitamin B12 level
A prescription drug, not a supplement. Generally safe under supervision but depletes B12 and carries a rare lactic acidosis risk. Its longevity benefit is unproven.
Anyone with kidney impairment, and it must never be self-prescribed.
Taking it without a doctor, skipping B12 monitoring, and assuming the longevity claim is established.
Preliminary (limited / small human data)
This is a prescription medication being used off-label for longevity in non-diabetic individuals. No completed human trial has demonstrated a lifespan or healthspan benefit in people without diabetes; the proposed TAME trial designed to test this has not yet reported results. Metformin may also blunt some adaptations to exercise training. Use only under physician supervision.
UK Prospective Diabetes Study (UKPDS) Group (1998). The Lancet, 352(9131), 854-865. RCT (metformin and diabetes complications). PMID: 9742977.